T-cell therapies for HIV: Preclinical successes and current clinical strategies.
about
CRISPR/Cas9 in allergic and immunologic diseases.Cell and Gene Therapy for HIV Cure.Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication.The Use of the Humanized Mouse Model in Gene Therapy and Immunotherapy for HIV and Cancer.
P2860
T-cell therapies for HIV: Preclinical successes and current clinical strategies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
T-cell therapies for HIV: Preclinical successes and current clinical strategies.
@en
type
label
T-cell therapies for HIV: Preclinical successes and current clinical strategies.
@en
prefLabel
T-cell therapies for HIV: Preclinical successes and current clinical strategies.
@en
P2093
P2860
P1433
P1476
T-cell therapies for HIV: Preclinical successes and current clinical strategies
@en
P2093
Catherine M Bollard
Douglas F Nixon
R Brad Jones
P2860
P304
P356
10.1016/J.JCYT.2016.04.007
P577
2016-06-02T00:00:00Z